UCB (EBR:UCB) UCB Media Room: Acquisitions and disposals of own shares
Transparency directive : regulatory news
11/06/2020 20:00
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jvMSFRv1ag-2FzyRNf0cQ629iGHgstdWg=
PIqlLyHfVL8xeSGCjhpjWR4BihxvdnfBQsJ2nv_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7=
KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1=
wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMK=
wi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZTycxmY8SJKhIQVC4pP-2FZU-2FhlRmtc2bePl66wqN=
ukwVgGLHv-2B7nRhe0-2FT7kTjkfvAF9Mezl-2Fcts1EEP-2BGGEsjSDUHuab9hdeVikFnDLp5b=
4Kq2bA8p9EXSWAgIU0YJpMfK0X6yGDXu9I9ude-2F8iHY9A-3D
** Acquisitions and disposals of own shares
------------------------------------------------------------
Brussels (Belgium), 11 June 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulated=
information
Acquisitions of own shares
In accordance with article 8:4 of the Royal Decree of 29 April 2019 executi=
ng the Belgian Code on Companies and Associations, UCB SA/NV (=E2=80=9CUCB=
=E2=80=9D or the =E2=80=9CCompany) (Euronext Brussels: UCB) hereby disclose=
s certain information in relation to its Share Repurchase Program 2020.=C2=
=A0
Under this program, UCB has requested a financial intermediary to repurchas=
e up to 1.2 million UCB shares on its behalf under the terms of an initial =
discretionary mandate agreement with validity until 15 June 2020, effective=
as from 25 March 2020, to cover current and future obligations under UCB's=
Long Term Incentive Plans for its personnel. The validity of this agreemen=
t has been extended from 15 June 2020 to 29 July 2020.
In the framework of this Share Repurchase Program 2020, UCB repurchased 209=
412 UCB shares on Euronext Brussels in the period from 2 June 2020 up to a=
nd including 10 June 2020, as follows:=C2=A0
=C2=A0
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmy8CAhKLmmKN4h9m87UQGSozSO-2BzIz=
65ZEA9UNlHdnFSsLPl4b5YlR6nqip9xevxBsWH_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7=
KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1=
wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMK=
wi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZbdVuY-2BG-2BS68DUbakiiUbkqcqagaJqCa-2BCaL5=
z-2FGCFGiwZvGb3XwsEsbv7AHsIHWeqLpJ0H-2BQeJ9r91KF8NApvC7nxxmVIY2C21Us1I-2FYr=
Hy96XqEiV3qLHq-2FWHMLGUZXv171wNkwobbzs785CaDW9k-3D
=C2=A0
=C2=A0Disposals of own sharesIn accordance with article 8:6 of the Royal De=
cree executing the Belgian Code of Companies and Associations, UCB announce=
s that, following exercises of stock options by members of its personnel, i=
t has disposed of UCB shares OTC in view of deliveries of these shares to t=
he relevant members of the personnel, within the framework of the Long Term=
Incentive Program of the UCB Group, as follows:
=C2=A0
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmuuA5t6a65-2BMxOviABIAjtUdyL9zYH=
HlF-2BSlbVgbirnZODyYr8398iPgnz6xiewvxKi__xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmR=
MKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZVmtu3qQqTo0VD1Uave5FKt7VMqkpPOfonYg-2FW6=
iC3g-2Bd4nracqLSLgtRkevgSUlQudo8lE9CCubaskpN2bTcQQVvvALyRWjIh-2FFgpwm4VpQp2=
AkCWNCCIRs1UK7SVu37M52CtI-2F0Rjqpb52S99beGY-3D
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3Dgm8z_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1Hx=
yuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEY=
ju79s6plkNQ3ZbVN8PgjEBK4UjtrV0ayZF-2FBlUqRJb4929ZRlpQyOaDu0xslUqbUkVgzoHkUy=
BquTfgXnJu8jE-2FPucTMkDK4T47LjbnrV-2FbnOxApNl6tQ8zBdDCoJGxwmgGxeyEN5lvbXNSg=
AwdMRCuBZJAtG6-2FbQps-3D .
Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com
Isabelle Ghellynck,
Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
GenericFile
2020611 - UCB Acquisitions and disposals of own shares (https://u7061146.ct=
.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B=
6enP299YDZ6RaBZwFkRnmx8j2S-2BbOYG6wnbCfnKAbrJCAHv5wDZ0tCHEFxYPLhbZVfs-3D2nP=
e_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-=
2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8=
z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZT6Qu=
l8OpsJvwzivYPqD3CNsaIfojalriawYI-2Fa2tPcUu8am1ZLG0MAkLlfK9tBdTBYpjlap8JSK1A=
gkSFgaYka-2BnmlabGkT4kqF4ejptIehqNtmihHVsZFq1tZv-2FmAkwKzknzUaiES21Ol-2F5js=
9E3w-3D GenericFile
2020611 - UCB Acquisitions and disposals of own shares (https://u7061146.ct=
.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B=
6enP299YDZ6RaBZwFkRnmx8j1AHYIVpY9AUL8IoXfvwu1RIo9hMTmsQznqq0J1i96Ng-3DOo___=
xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2F=
BZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5=
BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3Zdnp5Nf=
CfzjcgZD1nT9e91Krb4njTrHtThc4w8CV9mJLR4ociVaXaFEP7hSrRaXT-2Fh-2B61aUi1zsGXG=
3WJWTwWC-2Brm7lIaslH0SDiOGw8Qw7g7AhDz-2FXoYESGI-2FMUNAUOFMWfBdU60maK4yU17rL=
VipQ-3D GenericFile
20200611 - Verwerving en vervreemding van eigen aandelen (https://u7061146.=
ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-=
2B6enP299YDZ6RaBZwFkRnmx8jTY68IK9UyY1eUD-2Fhh6qkXhpnknqdBeEsP0HbmIdfhww-3Do=
9S2_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqdd=
W-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04Wwej=
U8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3Zd6=
bA0EGS-2FY-2BXbaPAlhF7DeMkAlOBMEvjkq3m8D8Ktwws-2BY5Y8u37H2HvWENkfy0JMN0Ksvd=
52NmzWCTHHGZkVauZZ0ni433sqT6rNJ7ABd0v6pHYRUDpVHen0c4oihPQqkJ92PiXnGMhzXjFMI=
DVa8-3D Image
Chart 1 June 11 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED=
-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmy8CAhKLmm=
KN4h9m87UQGSwgazbexVt0BOyJCd9fS6c-3DP1SF_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmR=
MKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZY0l1Xsj5PMcnoMUVkAHOH3cjOxhSYLbQTrq-2FDk=
0WhzMNEfYsoJtwpfiUzFaY7zbAe4Cl9m8UQsPFRes8m8leLs9dokRj6hI31Vc58G6wD7-2FV5-2=
FfZm-2F78twvYEMT6I7kZCegUeR1AOgp7ilsgu8-2Bsv0-3D Image
Chart 2 June 11 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED=
-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmuuA5t6a65=
-2BMxOviABIAjpdKt282yjcPazpMy7-2Bn4sM-3DoFGE_xDPID0vOuylFAU8fv4e60wei4JxqEG=
BdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2=
X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4B=
kAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZQPBfOPoo2M2Jv-2FcMAO7eMj2foyODuCvmp8=
XcCA1fVN6fIEhEANvs-2BJhQNhKA7IvIbF1TI73pxKvIAUXUyxHTh4irnwidk0tHIm-2FagXct6=
l1oh2ikecnP1f4L0i3Oq8lVdh82qUx9uvFmWWa1WxhAGA-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXzSjPqWpnrXN0g3pTsGoenfcG7hGuAsH=
s63OWpKhf0Lp2mkE5CumwzyZvGTQhVSPnfOdp9Bh3jSqeB71A1-2BlGh5Bf65JAY3ueDqRD7lrc=
XaY-3D227d_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6=
EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1M=
m04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6pl=
kNQ3ZSCUBhO9Hi3wDWF9L9Yvs67B-2BBAEbPxLeia09S9NmRigGYUOoPd1iWWflJ2rgrs7ZnK7P=
I3fv-2Fkddh94-2Bqvy1bgKNmcTemF-2BrkRdjo3Qst541q0zuX0MccETaCDtK6FiCgTpxB3w1M=
t3eP32K5ZsWNw-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=